Valuation: Diamond Biofund Inc.

Market Cap 15.1B 467M 410M 379M 348M 657M 45.06B 668M 4.53B 1.77B 22.05B 1.75B 1.72B 75.96B P/E 2024
-11x
P/E 2025 -12x
Enterprise Value 11.3B 350M 307M 283M 261M 492M 33.73B 500M 3.39B 1.33B 16.5B 1.31B 1.28B 56.85B EV / Sales 2024
-10.2x
EV / Sales 2025 -9.56x
Free-Float
16.16%
Yield 2024 *
-
Yield 2025 -
1 day-3.54%
1 week-14.70%
Current month-5.85%
1 month+6.95%
3 months+22.07%
6 months-0.56%
Current year+7.27%
1 week 17.65
Extreme 17.65
19.7
1 month 16.65
Extreme 16.65
22.4
Current year 12.05
Extreme 12.05
22.4
1 year 12.05
Extreme 12.05
22.4
3 years 12.05
Extreme 12.05
77.3
5 years 12.05
Extreme 12.05
200.19
10 years 12.05
Extreme 12.05
200.19
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-3.54%-14.70%-13.45%-74.02% 483M
-1.69%+1.74%-4.48%+41.06% 166B
-1.15%-0.02%+45.35%+129.16% 164B
-0.13%+3.30%+58.77%+244.14% 107B
-2.60%-2.96%-1.54%+92.03% 97.52B
-1.67%+0.86%-19.16%+51.08% 77.17B
+0.04%+1.31%+68.26%+163.16% 50.13B
-0.31%+3.84%-3.37%+49.29% 47.45B
-2.48%-7.10%-42.12%+28.62% 34.84B
-1.03%-0.42%+42.88%+124.88% 34.17B
Average -1.15%+0.45%+13.11%+84.94% 77.83B
Weighted average by Cap. -1.01%+1.66%+18.72%+106.21%

Financials

2024 2025
Net sales -2.23B -68.99M -60.47M -55.9M -51.41M -97M -6.65B -98.56M -668M -262M -3.26B -259M -253M -11.22B -1.07B -33.22M -29.12M -26.92M -24.76M -46.71M -3.2B -47.46M -322M -126M -1.57B -125M -122M -5.4B
Net income -2.52B -77.95M -68.32M -63.15M -58.08M -110M -7.52B -111M -755M -296M -3.68B -293M -286M -12.67B -1.17B -36.36M -31.87M -29.46M -27.1M -51.13M -3.51B -51.95M -352M -138M -1.72B -137M -134M -5.91B
Net Debt -5.01B -155M -136M -126M -116M -218M -14.96B -222M -1.5B -589M -7.32B -583M -570M -25.22B -3.8B -118M -103M -95.24M -87.59M -165M -11.34B -168M -1.14B -446M -5.55B -441M -432M -19.11B
Logo Diamond Biofund Inc.
Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.
Employees
29
Date Price Change Volume
26-07-19 NT$17.70 -3.54% 2,964,669
26-07-17 NT$18.35 -3.93% 6,631,224
26-07-16 NT$19.10 -0.78% 2,533,712
26-07-15 NT$19.25 +2.39% 3,449,094
26-07-14 NT$18.80 +0.27% 4,747,871
  1. Stock Market
  2. Stocks
  3. 6901 Stock